Your browser doesn't support javascript.
loading
CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion.
Mou, Haiwei; Smith, Jordan L; Peng, Lingtao; Yin, Hao; Moore, Jill; Zhang, Xiao-Ou; Song, Chun-Qing; Sheel, Ankur; Wu, Qiongqiong; Ozata, Deniz M; Li, Yingxiang; Anderson, Daniel G; Emerson, Charles P; Sontheimer, Erik J; Moore, Melissa J; Weng, Zhiping; Xue, Wen.
Afiliação
  • Mou H; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA.
  • Smith JL; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA.
  • Peng L; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA.
  • Yin H; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.
  • Moore J; Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, MA, 01605, USA.
  • Zhang XO; Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, MA, 01605, USA.
  • Song CQ; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA.
  • Sheel A; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA.
  • Wu Q; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.
  • Ozata DM; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA.
  • Li Y; Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, MA, 01605, USA.
  • Anderson DG; Department of Bioinformatics, School of Life Science and Technology, Tongji University, Shanghai, People's Republic of China.
  • Emerson CP; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.
  • Sontheimer EJ; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.
  • Moore MJ; Harvard-MIT Division of Health Sciences & Technology, Cambridge, MA, 02139, USA.
  • Weng Z; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Xue W; Wellstone Muscular Dystrophy Program, Department of Neurology, University of Massachusetts Medical School, Worcester, MA, 01605, USA.
Genome Biol ; 18(1): 108, 2017 06 14.
Article em En | MEDLINE | ID: mdl-28615073
ABSTRACT
CRISPR is widely used to disrupt gene function by inducing small insertions and deletions. Here, we show that some single-guide RNAs (sgRNAs) can induce exon skipping or large genomic deletions that delete exons. For example, CRISPR-mediated editing of ß-catenin exon 3, which encodes an autoinhibitory domain, induces partial skipping of the in-frame exon and nuclear accumulation of ß-catenin. A single sgRNA can induce small insertions or deletions that partially alter splicing or unexpected larger deletions that remove exons. Exon skipping adds to the unexpected outcomes that must be accounted for, and perhaps taken advantage of, in CRISPR experiments.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Genoma Humano / Éxons / Sistemas CRISPR-Cas / Edição de Genes Limite: Humans Idioma: En Revista: Genome Biol Assunto da revista: BIOLOGIA MOLECULAR / GENETICA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Genoma Humano / Éxons / Sistemas CRISPR-Cas / Edição de Genes Limite: Humans Idioma: En Revista: Genome Biol Assunto da revista: BIOLOGIA MOLECULAR / GENETICA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos